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Abstract Five recombinant hairpin loop variants of chicken cys- 
tatin (AV55, AV55-$56, zIPI03-L105, AI102-Q107, loop2-KD2) 
~ere constructed by cassette mutagenesis, expressed in E. coli, 
purified to homogeneity, characterized by protein-chemical 
means and by their inhibitory properties. The variant forms, 
modified in two of the three postulated cysteine proteinase binding 
regions, were inhibitorily active. However, the equilibrium disso- 
ciation constants of the complexes between papain as well as 
human cathepsin B or L and the cystatin variants show a weaker 
affinity for all three enzymes compared with recombinant chicken 
cystatin. These results prove the contribution of both hairpin 
loops to complex formation with the three enzymes. Furthermore, 
the kinetic constants indicate discrete differences in the molecular 
mechanism of interaction between chicken cystatin and papain, 
cathepsin B, and cathepsin L. Inhibition of cathepsin L was much 
less affected than inhibition of papain or catbepsin B by the 
modifications achieved in the five variants. Remarkably, at high 
enzyme concentration (above 0.5 nM) inhibition of papain by 
these variants was 'temporary', that means, active papain was 
released from the enzyme-inhibitor complex within minutes to 
hours (compare [1]). 
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~. Introduction 
Chicken cystatin, a small protein-type inhibitor of cysteine 
proteinases, represents a well studied member of the cystatin 
,uperfamily (for reviews ee [2,3]). It was shown to be a revers- 
ble tight-binding inhibitor of papain and papain-like nzymes 
4Corresponding author. Fax: (49) (89) 5160 4735. 
E-mail: <auerswald@clinbio.med.uni-muenchen.de> 
tbbreviations. E-64, t.-3-carboxy-2,3-trans-epoxy-propionyl-leucyl- 
~Lmido-(4-guanidino)butane; NH-Mec, 7-(4-methyl) coumaryl-amide; 
.5, benzyloxycarbonyl; rCC, AEF-[S1M, M29I, M89L] chicken cys- 
atin, (recombinant chicken cystatin); AV55, AEF-[S1 M, M29I, AV55, 
VI89L] chicken cystatin; AV55-$56, AEF-[S1M, M29I, AV55, AS56, 
VI89L] chicken cystatin; loop2-KD2, AEF-[S 1 M, M29I, M89L, S 101 I, 
1102D, P103I, Wl04Q, L105, N106R, Q107I, I108A] chicken cystatin; 
1P103-L105, AEF-[S1M, M29I, M89L, AP103, AWl04, ALl05,] 
chicken cystatin; AI 102-Q 107, AEF-[S 1 M, M29I, M89L, AI 102, AP 103, 
AWl04, ALl05, AN106, AQ107] chicken cystatin; N-del 2, [AS1-P11, 
V12A, PI3E, V14F, DI5M, M29I, M89L] chicken cystatin. 
[4-9]. Synthetic genes of chicken cystatin and variants of them 
have been expressed and characterized [10-12]. Crystal and 
solution structures of native and recombinant chicken cystatin 
are known [13,14] and a model of the interaction of chicken 
cystatin with papain has been proposed [7,13]. According to the 
so-called 'elephant-trunk model', the enzyme-inhibitor com- 
plex is formed mainly by hydrophobic interactions between 
chicken cystatin and the complementary active-site cleft of pa- 
pain, whereby cystatin contributes the N-terminal 'trunk' 
(Leu7-Gly9), the first hairpin loop (Gln53-Gly57) and the second 
hairpin loop (Pro]°3-Leul°5). The validity of this model was 
confirmed by elucidation of the structure of the complex 
formed between S-carboxymethylated papain and stefin B [15] 
as well as by kinetic data obtained for the interactions of native 
and/or modified cystatins with different cysteine proteinases 
[7,8,12,16]. 
Detailed analyses of the N-terminal segments of chicken cys- 
tatin and human cystatin C indicate a substrate-like interaction 
of this region with residues of the subsites $3 and $2 of the 
proteinase. Especially the amino acid residues preceding the 
conserved Gly 9 of chicken cystatin or Gly ~1 of human cystatin 
C have distinct but different effects on the binding to papain, 
actinidin, ficin, cathepsin B or cathepsin L [17 20]. 
The contribution of the first hairpin loop of cystatins to 
complex formation has not yet been investigated in such detail. 
From studies with KVVAG- and QVTAG-mutants of cystatin 
A, Nikawa et al. [21] proposed that the first hairpin loop is not 
essential for cysteine proteinase inhibition. But the importance 
of this region is strongly suggested by (i) the structural data of 
the crystallized stefin B-papain complex [15], (ii) its conserved 
primary structure (QxVxG-region) [2] and (iii) inhibition prop- 
erties measured with substitution variants of oryzacystatin [22] 
and chicken cystatin [12]. The latter data provide first evidence 
that amino acid residues of this region are partially responsible 
for the distinct affinities of cystatins for different cysteine pro- 
teinases. However, no data have been presented so far on var- 
iants of the first hairpin loop missing conserved amino acid 
residues. 
Little is known about the importance of the second hairpin 
loop for the stability of the molecule itself or its contribution 
to complex formation. Using spectroscopic methods, Lindahl 
and co-workers [6] demonstrated that Trpl°4 of chicken cystatin 
must be involved in the interaction with papain. These early 
data were confirmed indirectly by the interaction model [13] 
and by the stefin B papain complex structure [15]. 
In this report we present data on construction and expression 
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of deletion and substitution hairpin loop variants of chicken 
cystatin, on their purity and their altered inhibition behaviour 
towards papain and human cathepsin L and B. In addition, we 
present evidence for temporary inhibition of papain by these 
hairpin loop variants. The mechanism of this new and unex- 
pected behaviour is described in more detail in an accompany- 
ing paper [1]. 
2. Mater ia ls  and methods 
2.1. Materials 
All chemicals used were obtained from Sigma, St. Louis, USA; 
Merck, Darmstadt, Germany; Serva, Heidelberg, Germany; Biomol, 
Hamburg, Germany; Fluka, Buchs, Switzerland; they were all of ana- 
lytical grade if not otherwise specified. Restriction endonucleases and 
DNA modifying enzymes were purchased from Boehringer, 
Mannheim, Germany and New England Biolabs, Beverly, USA. Natu- 
ral chicken egg white cystatin was a generous gift of V. Turk, Ljubljana, 
SLO. AEF [S1M, M29I, M89L] chicken cystatin (rCC) is a recombi- 
nant variant which behaves like the natural unphosphorylated form of 
chicken cystatin [11] and has the same conformation as natural chicken 
cystatin [14]. Anti-chicken cystatin antibodies and the variants V55D 
and N-del 2 are described elsewhere [12,20]. 
2.2. Molecular cloning, cassette mutagenesis, and expression of the 
variants 
Standard techniques of molecular cloning were performed according 
to Sambrook et al. [23]. The constructions ofAV55, AV55-$56, AP103- 
L105, AI102-QI07 and loop2-KD2 were performed by cassette mut- 
agenesis using the synthetic ystatin gene. Briefly, the large Xbal-PstI 
fragment of pGG 8.1.1, [10] was substituted by appropriate deleted 
DNA sequences for AV55 and AV55-$56. The large DralII-XhoI frag- 
ment was substituted by fragments with deletions for AP103-L105 and 
AI102-Q107 or with the fragment for loop2-KD2 having the sequence 
5' g tgc acc ttc gtt gtt tac ATC GAC ATC CAG CTG CGT ATC GCT 
aaa ctt c 3' (capital etters indicate the substituted nucleotides). The 
construction of periplasmic expression vectors, the transformation of
E. coli TG1, the analysis of transformants (restriction analysis of plas- 
mids, DNA sequencing, expression analysis of E. coli lysates by SDS- 
PAGE) were performed as described [12]. 
2.3. Purification of the &hibitor variants and determination f
concentration 
All variants were isolated from periplasmic E. coli fractions [24]. The 
loop2-KD2 variant was purified by carboxymethylpapain ffinity 
chromatography [25] whereas the zlV55, AV55-$56, AP103-LI05 and 
/l1102-Q 107 variants were purified by immunoaffinity chromatography 
using sheep antibodies directed against chicken cystatin (100 mg IgGs) 
and loaded on CNBr-activated Sepharose 4B (5 g) [20]. Protein concen- 
tration was determined from absorbance at 280 nm using Az80 (1%) 
values calculated from the content of aromatic residues and cystines 
according to Mach et al. [26]. 
2.4. SDS-PA GE, Western blot analysis and isoelectric focussing 
SDS-PAGE of the proteins was performed in 10-20% poly- 
acrylamide gels following the procedure of Laemmli [27]. Immunose- 
lected anti(chicken cystatin) IgGs were used for Western blot analysis 
[28]. Isoelectric focussing was performed with the PhastSystem (Phar- 
macia) using the calibration kit pH 3 10. 
2.5. HPLC analysis and amino acid sequencing 
Purified samples of all variants (usually 2-3 nmol) as well as tryptic 
digests of selected variants were analysed by reversed phase-HPLC as 
detailed previously [11]. Amino acid sequence analyses of the N-termini 
of all variants and of the modified Tp 14 peptide [11] of the AI 102-Q 107 
variant were done with a gas-phase sequencer 473A (Applied Biosys- 
tems GmbH, Weiterstadt, Germany) following the instructions of the 
manufacturer. 
2.6. Mass spectrometry 
Solutions of the purified variants AV55, AV55-$56, AP103-L105 and 
loop2-KD2 were infused (5/tl/min) into an atmospheric pressure ioni- 
zation source fitted to the tandem quadrupole instrument API III 
(Sciex, Thornhill, Ontario, Canada). The average molecular mass val- 
ues of the proteins were calculated from the m/z peaks in the charge 
distribution profiles of the multiple charged ions [29,30]. 
2. Z Determination of kinetic constants 
Kinetic constants for the interaction of the inhibitor variants with 
cysteine proteinases were determined applying kinetic enzyme assays at 
30°C and pH 5.5 with the fluorogenic substrate Z-Phe-Arg-NH-Mec 
as described in detail elsewhere [1,31]. Rate constants, ko, and ko~, were 
obtained by presteady-state nalyses [32]. Equilibrium dissociation con- 
stants (K0 were measured directly in equilibrium inhibition experiments 
or calculated (Ki = koJko.) from presteady-state experiments, and were 
corrected for substrate competition. Substrate consumption was less 
than 5% in all experiments. 
All calculations are based on inhibitorily active concentrations of the 
variants determined inseparate kinetic assays under equilibrium condi- 
tions (Et/~ = 2-60) using E-64-titrated papain (4 nM) [33] and Bz-Arg- 
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Fig. 1. Scheme and amino acid sequences of chicken cystatin and the designed recombinant variants. Amino acids are given by the one letter code. 
Boxes indicate identical amino acids (if not otherwise stated) and lines between boxes represent an internal deletion, shaded areas indicate the 
conserved cystatin sequences of the N-terminus, the first and the second hairpin loop. Secondary structural elements seen in the crystal and in solution 
are indicated above the sequences; fl sheets are identified by letters; the 'chameleon' symbolizes the C71-M89 region whose structure apparently 
changes according to its enviroment [13,14]. 
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i'ig. 2. SDS-PAGE (10-20%)of recombinant chicken cystatins. Purified 
ahibitor preparations were applied in amounts of 3-5 fig/slot. Lanes: 
, rCC; 2, variant AV55; 3, variant AV55-$56; 4, variant AP103-L105; 
, variant AI102-Q107; 6,variant loop2-KD2; positions of molecular 
nass protein markers are indicated. 
qH-Mec (10/.tM) or chicken cystatin-titrated cathepsin L (0.4 nM) and 
quc-Leu-Tyr-NH-Mec (60/tM). Briefly, the residual activity at equilib- 
:ium was measured after addition of increasing volumes of inhibitor 
olution. Entering the defined enzyme concentration asfixed parame- 
er, both the concentration f the added inhibitor solution and K~ were 
~btained by non-linear regression analysis using the general equation 
3escribing tight-binding inhibition [34]. 
3. Results and discussion 
~. 1. Construction and expression of the hairpin loop variants 
The amino acid sequences of chicken cystatin, recombinant 
:hicken cystatin and the hairpin loop variants are shown in Fig. 
1 together with a schematic drawing of the secondary structural 
dements. 
The genes of the mutants, constructed by cassette mutagene- 
~is and ligated into an ompA expression vector, were expressed 
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in E. coli TG1 cells. Positive transformants were identified after 
induction of transcription and analysis of E. coli lysates by 
SDS-PAGE and limited DNA sequencing (data not shown). 
The level of expression was about 2.5 -4 rag/liter fermentation 
broth (estimated after SDS-PAGE) and the titer was 1.4 × 1012 
cells/liter. 
An additional deletion variant lacking the complete first hair- 
pin loop, AL54-I58, could be expressed only in minor amounts 
and the purified material was not stable during kinetic measure- 
ments. We conclude, therefore, that the five amino acid residues 
of the first hairpin loop are indispensible for the overall fold 
and stability of the cystatins. 
3.2. Purification and protein chemical characterization 
The five variants were isolated after shaker-flask fermenta- 
tion (1-6 liter) from E. coli periplasma fractions. The loop2- 
KD2 variant (1.5 mg/1 fermentation broth) was purified by 
carboxymethyl papain affinity chromatography. The yields of 
the variants AV55, AV55-$56, AP103-L105, AI102-Q107, puri- 
fied by immunoaffinity chromatography, were in the same 
range. Each variant showed a single, homogeneous protein 
band in SDS-PAGE. Four variants migrated at a position cor- 
responding to Mr of 15,000 Da, the variant AI102-Q107 mi- 
grated at 14,300 Da (Fig. 2). With the exception of the loop2- 
KD2 variant, distinct and well comparable immunological de- 
tection reactions were observed by Western blotting and im- 
munoprinting, but staining was less intense than with chicken 
cystatin (data not shown). The very weak staining observed 
with loop2-KD2 variant indicates a high immunoreactivity of 
the exposed amino acid residues in the second hairpin loop of 
chicken cystatin with our antibody. 
HPLC analysis on RP-Cls columns confirmed the homoge- 
neity o f AP 103-L 105, AI 102-Q 107 and loop2-KD2 variant (data 
not shown). The AV55 and AV55-$56 variant appeared as two 
closely related peaks, both being inhibitorily active against pa- 
pain. Amino acid sequencing and mass spectrometry indicated 
that each second peak represents the acetylated form of the 
corresponding variant (data not shown). The first five N-termi- 
nal amino acids were confirmed in all variants. Average molec- 
ular masses were estimated by mass spectrometry to 13,401 Da 
(acetylated form: 13,443.8 Da) for variant AV55; to 13,314 Da 
(acetylated form: 13,356.8 Da) for variant AV55-$56; to 13,105 
Fable 1 
Equilibrium dissociation constants (K,) and rate constants (ko., kof0 of the complexes between recombinant hairpin loop variants of chicken cystatin 
~nd cysteine proteinases 
Inhibitor Cathepsin L Papain Cathepsin B
kon koft K i ko. koff Ki K i 
(M -1 "s -1) (s -I) (nM) (M -1 "s -t) (s -t) (nM) (nM) 
rCC 7.8 × 10 7 6.7 × 10 -5 0.0009 1.3 X 10 7 1.8 X 10 -5 0.0014 4.5 
N-del 2 n.d. n.d. 1.63 n.d. n.d. 166 ~ 50,000 
V55D 3.0 × 10 7 5.8 × 10 -5 0.0019 1.3 × 10 7 1.2 × 10 -2 0.923 3,960 
LtV55 9.2 × 10 7 5.4 × 10 -4 0.0059 n.d. n.d. 361 18,000 
/IV55-$56 7.7 X 10 7 3.5 × 10 3 0.0455 n.d. n.d. 741 -> 50,000 
AP103-L105 7.9 × 10 7 2.3 × 10 -4 0.0029 5.4 × 106 1.1 × 10 -5 2.15 254 
~I102-Q107 3.9 × 10 7 3.3 × 10 -4 0.0085 n.d. n.d. 1.64 293 
loop2 KD2 1.7 × 10 7 5.5 × 10 -5 0.0032 3.8 × 10 6 2.8 X 10 -3 0.737 5,870 
The corresponding data for recombinant wild type chicken cystatin, AEF-[S IM, M29I M89L] chicken cystatin (rCC) [11] and the N-terminal deletion 
variant [AS1-P11, VI2A, PI3E, VI4F, D15M, M29I, M89L] chicken cystatin (N-del 2) [20] are included for comparison, .d., not determined (see 
text for reasons). 
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Fig. 3. Effect of mutations on the unitary free energy change (AG °) for complex formation. The AG O (var) for the binding reaction of the individual 
variants to the different enzymes were calculated from K~ (var) according to AGO (var) = RT lnKi (var) and the differences AGO (rCC)-AGO (vat) were 
expressed in% of AG ° (rCC), abbreviated as A(-AGO) on the ordinate; black boxes indicate cathepsin L, squared boxes indicate papain and dotted 
boxes indicate cathepsin B. 
Da for variant AP103-L105; and to 13,472 Da for variant loop2- 
KD2. The molecular mass of the AI102-Q107 variant was not 
determined, but the deletion in this variant was confirmed by 
tryptic peptide mapping and amino acid sequencing of the 
modified Tpl4-equivalent peptide (for comparison see [11]). 
Isoelectric focussing of both variants, AV55 and AV55-$56, 
resulted in two silver-stained protein bands, each located at pI 
5.4 and 5.9, which probably correspond to the acetylated and 
non-acetylated forms (theoretical pI 5.9). Variant loop2-KD2 
showed two strong bands at pI 5.8 and 5.9 (theoretical pI 6.0), 
whereas each of the variants AP103-L105 and AI102-Q107 
showed one major band at pI 5.9 and pI 5.8, respectively 
(theroretical pI 5.9) in addition to some minor bands (data not 
shown). Such heterogeneities in isoelectric focussing are often 
found with recombinant proteins but are difficult to interpret. 
3.3. Inhibitory profile of the variants 
The specific inhibitory activity of the variants was found to 
be between 13-45% compared to 48% of wild type and to 
6-52% of other cystatin variants [12], values that are typical for 
recombinant cystatin inhibitors. However, this relatively low 
specific inhibitory activity, determined also in material success- 
fully used for NMR spectroscopy [14], cannot be explained 
satisfactorily. Table 1 summarizes the measured K~ values and 
rate constants, based on inhibitorily active protein concentra- 
tions. Determination of rate constants was not feasible when 
complex formation was too fast to be analyzed without 
stopped-flow techniques. Collectively, the analysed mutants 
differ from chicken cystatin in their reduced affinity for papain 
and cathepsin B and L. As far as available, the rate constants 
indicate that the increased Ki values are due to a lower stability 
of the complexes (increased koff ) rather than an impaired asso- 
ciation rate. The magnitude of the effect of mutations on K~ 
varies with the nature of the affected loop as well as with the 
target enzyme. From the Ki values, we calculated the unitary 
free energy changes of complex formation, which represent 
suitable additive parameters for interpretation of the effects of 
individual mutations [16]. Fig. 3 visualizes the reduction of the 
unitary free energy change of complex formation caused by the 
individual deletions or substitutions, expressed in% of the uni- 
tary free energy change of complex formation with wild type 
chicken cystatin. 
Within the first hairpin loop, the effect of mutations on V55 
and $56 increases from the substitution (V55D) over the single 
V55 deletion to the V55-$56 double deletion. This is in good 
accordance with the structure of the stefin B-papain complex 
where the corresponding residues (V55, A56) form most of the 
hydrophobic contacts in this region [15]. 
The three mutations in the second hairpin loop seem to have 
a significantly lower effect on the stability of the molecule and 
on the affinity for papain, cathepsin B and cathepsin L than 
mutations in the first hairpin loop or the deletion of the N- 
terminal trunk (see Table 1 and Fig. 3). Complete deletion of 
the second hairpin loop (AI102-Q107) does not further educe 
the free energy change observed uring complex formation if 
compared to the deletion of only three residues in this loop 
(ziP 103-L 105). This is an indirect evidence that these amino acid 
residues do not have a significant influence on the overall struc- 
ture of the molecule. Interestingly, substitution of the second 
hairpin loop by the sequence of the second domain of the 
kininogen heavy chain (loop2-KD2 variant) reduces the free 
energy change during complex formation with papain by about 
the same degree as complete deletion of the second hairpin 
loop. The second hairpin loop of KD2 was selected for substi- 
tution because its sequence is markedly different from the cor- 
responding sequences of all other cystatins [3]. Keeping in mind 
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I-g. 4. Temporary inhibition of papain by variant AP103-L105: Effect of enzyme concentration. Continuous ltuorometric detection of papain activity 
slaowing the concentration ofreaction product (P) and the actual reaction rate (v) as function of time. After complete thiol activation of enzyme, 
the variant API03-L105 was added (arrows). (A) 0.006 nM papain assayed with Z-Phe-Arg-NHMec as substrate (10 pM), 6.3 nM inhibitor; (B) 0.6 
nM papain assayed with Bz-Arg-NHMec (100/IM), 8.5 nM inhibitor; (C) 4.0 nM papain assayed with Bz-Arg-NHMec (10/,tM), 16.8 nM inhibitor. 
taat the proteolytically isolated KD2 domain is an effective 
iahibitor of papain (K~ = 0.017 nM), this observation suggests 
tlmt all three binding regions contribute to an optimal fit of the 
ontiguous wedge-like surface into the complementary active- 
sJte cleft of papain, and that this fit can be distorted strongly 
t'y a 'wrong' combination of loops. Binding to cathepsin B is 
even more affected by insertion of a 'wrong' second hairpin 
l,)op (loop2-KD2) than by its deletion. This may be explained 
by steric collision with the so-called occluding loop ofcathepsin 
I~, which has been predicted to interfere with binding of the 
~econd hairpin loop of cystatins [35]. 
Most surprisingly, inhibition of cathepsin L is only slightly 
,eeaker by the five hairpin loop variants if compared with wild 
ype cystatin (see Table). In complex formation with cathepsin 
i,, the contributions of the amino acids mutated in the hairpin 
loop regions eem to be less important than the deletion of the 
N-terminal trunk. However, the magnitude of the effect of 
'xl-terminal truncation on binding to cathepsin L is also lower 
'~ hart on binding to papain (see Fig. 3). Evidence for this excep- 
ional insensitivity of cathepsin L to cystatin hairpin loop mu- 
tations had been obtained already in previous studies with 
-ubstitution mutants of the first hairpin loop [12]. 
Although the primary structures of papain and cathepsin L
tre very similar [36], inspection of the contact region of papain 
.vith human stefin B [15] reveals significant differences in the 
runk and second hairpin loop binding regions. The trunk bind- 
ng region of cathepsin L shows a replacement of three basic 
• esidues (Arg 58, Arg s9 and Arg jl] of papain) for three acidic 
'esidues (Glu 63, Asp 7t and Asp TM of cathepsin L). This charge 
"eversal would complement the cystatin amino terminal se- 
tuence Arg4-SerS-Arg 6 (P6-P4), and could allow specific salt 
~ridge formation. The results presented here indicate that bind- 
ng of chicken cystatin and its variants to cathepsin L is also 
mproved in the hairpin loop regions. A hydrophobic/aromatic 
~'eplacement (papain Phe~4~-Gln-Leu-Tyr-> cathepsin L Phe 143- 
Leu-Phe-Tyr) is seen in the vicinity of the second hairpin loop; 
it is therefore conceivable that this segment allows more favour- 
~ble burial of cystatin Trp~°4-Leu ~°5. 
3.4. Temporary inhibition 
When the hairpin loop variants were assayed with high con- 
centrations of papain (above 0.5 nM), inhibition was not con- 
stant and a time-dependent recovery of enzymatic activity was 
observed (Fig. 4). This phenomenon has previously been de- 
scribed for serine proteinase inhibitors as temporary inhibition 
[37]. As shown in detail in an accompanying paper [1], the 
temporary inhibition by chicken cystatin variants is due to 
complex formation followed by substrate-like cleavage of the 
Glyg-Ala ~° bond, resulting in truncated inhibitors of much 
lower or neglegible affinity. According to the kinetic model 
describing this interaction, cleavage is expected and was found 
to be extremely slow at low enzyme concentration (see Fig. 4) 
resulting in apparently normal inhibition under these condi- 
tions and, therefore, it did not affect determination ofthe K~val- 
ues and rate constants presented in Table 1. However, due to 
temporary inhibition, true titration experiments (EtIKi > 100) 
[34] requiring high enzyme concentrations were not possible, 
and the active concentration of inhibitors had to be calculated 
from experiments performed under equilibrium or incomplete 
titration conditions (EtlK i = 2-60). This approach yields relia- 
ble results as long as active enzyme and inhibitor concentra- 
tions are similar. 
3.5. Conclusions 
Pure, homogenous and stable deletion as well as substitution 
variants of both hairpin loops of chicken cystatin were pro- 
duced. All variants inhibit papain as well as cathepsin B and 
L, but weaker than chicken cystatin. The general interaction 
model of chicken cystatin with papain [7,8,13] was confirmed 
experimentally: aspredicted, both hairpin loops as well as the 
N-terminal trunk of the inhibitor contribute to complex forma- 
tion. However, the contributions of the three binding regions 
to the free energy change during complex formation seem to be 
not simply additive. In the interaction with papain and cathep- 
sin B, the contribution of the second hairpin loop is signifi- 
cantly lower than that of the first hairpin loop and than that 
of the N-terminal binding region. Furthermore, mutations in 
184 E.A. AuerswaM et al./FEBS Letters 361 (1995) 179 184 
both hairpin loops can affect the binding mode of the inhibitor 
to papain in a way that the Gly9-Ala ~° bond of the inhibitor is 
cleaved like a peptide substrate (see [I] for details). Inhibition 
of cathepsin L is only slightly reduced by the selected hairpin 
loop mutations. Hence, it is shown indirectly that the three 
contact regions of the inhibitor epresent an excellent binding 
surface, formed complementary to the active-site cleft of 
cathepsin L, but additional sites or regions, not identified so far, 
could be important for the strong interaction with cathepsin L. 
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